How is resistant hypertension defined and what steps are typically taken to evaluate and manage it?

How is resistant hypertension defined and what steps are typically taken to evaluate and manage it?

• A. BP above goal despite adherence to two antihypertensive drugs.
• B. BP at goal with lifestyle changes alone.
• C. BP fluctuates widely but below threshold.
• D. BP above goal despite adherence to three antihypertensive drugs including a diuretic.

Answer: (D)

Resistant hypertension means blood pressure stays above the goal despite taking three antihypertensive drugs from different classes at adequate doses and with good adherence, and one of those drugs is a diuretic. This definition emphasizes two things: true treatment resistance (not controlled BP despite comprehensive therapy) and the need for a diuretic as part of the regimen, since volume overload is a common driver of high pressures. To evaluate this situation, start by confirming that the elevated BP isn’t due to measurement error or a nonrisk situation. Use accurate office technique and supplement with home blood pressure monitoring or ambulatory monitoring to rule out white coat or masked hypertension. Verify that the patient is actually taking the medications as prescribed and that there are no factors driving BP up, such as nonsteroidal anti-inflammatory drugs, stimulants, excess salt intake, or alcohol. After ensuring true resistance, look for secondary causes that could be elevated contributors, like sleep apnea, chronic kidney disease, or endocrine problems, and check labs for electrolyte disturbances, kidney function, and thyroid status. Management typically proceeds by optimizing the current three-drug regimen and addressing lifestyle factors. Ensure the diuretic is a thiazide-like agent (such as chlorthalidone) given at an effective dose, along with two other appropriate drugs (often an ACE inhibitor or ARB, and a calcium channel blocker). If blood pressure remains above goal, add a mineralocorticoid receptor antagonist such as spironolactone or eplerenone, with careful monitoring of potassium and kidney function. Alongside pharmacologic optimization, emphasize nonpharmacologic steps: sodium restriction, weight reduction if needed, physical activity, treatment of sleep apnea if present, and limiting substances that raise BP. If resistance persists after maximizing therapy and addressing secondary causes, specialist referral and consideration of other advanced therapies may be appropriate.

Resistant hypertension means blood pressure stays above the goal despite taking three antihypertensive drugs from different classes at adequate doses and with good adherence, and one of those drugs is a diuretic. This definition emphasizes two things: true treatment resistance (not controlled BP despite comprehensive therapy) and the need for a diuretic as part of the regimen, since volume overload is a common driver of high pressures.

To evaluate this situation, start by confirming that the elevated BP isn’t due to measurement error or a nonrisk situation. Use accurate office technique and supplement with home blood pressure monitoring or ambulatory monitoring to rule out white coat or masked hypertension. Verify that the patient is actually taking the medications as prescribed and that there are no factors driving BP up, such as nonsteroidal anti-inflammatory drugs, stimulants, excess salt intake, or alcohol. After ensuring true resistance, look for secondary causes that could be elevated contributors, like sleep apnea, chronic kidney disease, or endocrine problems, and check labs for electrolyte disturbances, kidney function, and thyroid status.

Management typically proceeds by optimizing the current three-drug regimen and addressing lifestyle factors. Ensure the diuretic is a thiazide-like agent (such as chlorthalidone) given at an effective dose, along with two other appropriate drugs (often an ACE inhibitor or ARB, and a calcium channel blocker). If blood pressure remains above goal, add a mineralocorticoid receptor antagonist such as spironolactone or eplerenone, with careful monitoring of potassium and kidney function. Alongside pharmacologic optimization, emphasize nonpharmacologic steps: sodium restriction, weight reduction if needed, physical activity, treatment of sleep apnea if present, and limiting substances that raise BP. If resistance persists after maximizing therapy and addressing secondary causes, specialist referral and consideration of other advanced therapies may be appropriate.